title: [Evolution of prostate cancer brachytherapy].
abstract: Curietherapy, more commonly named brachytherapy, is one of the oldest irradiation techniques used for prostate cancer. Prostate brachytherapy evolved according to the scientific and technological progress. After a historical reminder of the evolution of prostate brachytherapy, different technical aspects are discussed: low-dose rate brachytherapy using permanent or temporary implants, high-dose rate brachytherapy as well as new imaging modalities. Prostate brachytherapy indications are listed regarding to the evidence-based medicine data for low, intermediate and high risks prostate cancers. Potential indications and new research programs (focal therapy, high-dose rate, single-dose brachytherapy) are also presented.
authors.affiliation: Département de radiothérapie, Université Nice-Sophia, centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice Cedex, France. jean-michel.hannoun-levi@nice.unicancer.fr
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Hannoun-Levi
authors.forename: Daniel
authors.initials: D
authors.lastname: Chevallier
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Cosset
authors.forename: Alain
authors.initials: A
authors.lastname: Gerbaulet
mesh_terms: D001918:Brachytherapy / Q000379:methods* / Q000639:trends; D019317:Evidence-Based Medicine; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D010165:Palladium / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011835:Radiation Protection / Q000379:methods; D011868:Radioisotopes / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D012306:Risk
chemical_list: D007457:Iodine Radioisotopes; D011868:Radioisotopes; D010165:Palladium